中科ZK品牌怎么样 申请店铺

我要投票 中科ZK在番茄红素行业中的票数:771 更新时间:2026-01-28
中科ZK是哪个国家的品牌?「中科ZK」是 中科健康产业集团股份有限公司 旗下著名品牌。该品牌发源于江苏,由创始人冯鹏在1990期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力中科ZK品牌出海!将品牌入驻外推网,定制中科ZK品牌推广信息,可以显著提高中科ZK产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

中科ZK怎么样

中科健康产业集团股份有限公司成立于1984年,主营中药及中药保健品的研制、生产与销售,拥有国内一流的GMP生产流水线和强大的研发中心。

中科集团以强大的人才实力为支撑,骨干成员均为研究员、高级工程师、博士、硕士。中科产品几乎涵盖所有领域(抗肿瘤、肝、心脑血管、糖尿病、美容、大众保健等系列),销售网络遍布全国三十多个省市、自治区以及海外多个国家和地区。

中科集团现已获得国家卫生部、药监局53项保健食品批文,自主研发批文数量在行业内位居前列。药品研发方面,目前具有新药证书2个,自主知识产权新药临床批件2个,正在进行二期和三期临床研究。目前拥有国内、国际专利113项(其中发明专利36项),并有一项为PCT国际发明专利。

中科是江苏省高新技术企业,在同行业中率先通过ISO9001质量管理体系、ISO14001环境管理体系及OHSAS18001职业健康安全管理体系认证,并且第一批获得国家进出口自营权。中科商标为江苏省著名商标。2010年中科集团入选上海世博会企业联合馆。

中科集团拥有国内一流的高标准实验室及检测室,其下属南京中科药业有限公司拥有目前国内先进的保健品生产厂房。生产车间无菌达到万级标准,主要操作台经多层空气净化,可达到百级标准,各种硬件设备达到先进医药企业标准,生产区全封闭作业且达到十万级标准。

中科专注于中药保健品生产研发,努力成为行业领军企业。

Established in 1984, China Science Health Industry Group Co., Ltd. is mainly engaged in the research, production and sales of traditional Chinese medicine and traditional Chinese medicine health products. It has a first-class GMP production line and a strong R & D center in China. Supported by a strong talent strength, the core members of China Science and technology group are researchers, senior engineers, doctors and masters. Zhongke products cover almost all fields (anti-tumor, liver, cardio cerebrovascular, diabetes, beauty, public health and other series), and its sales network covers more than 30 provinces, autonomous regions and overseas countries and regions. China Science and Technology Group has obtained 53 health food approvals from the Ministry of health and the State Food and drug administration, and the number of independent R & D approvals ranks first in the industry. In terms of drug research and development, at present, there are 2 new drug certificates, 2 new drug clinical approvals with independent intellectual property rights, and phase II and phase III clinical studies are under way. At present, it has 113 domestic and international patents (including 36 invention patents), and one PCT international invention patent. Zhongke is a high-tech enterprise in Jiangsu Province. It is the first one in the same industry to pass the ISO9001 quality management system, ISO14001 environmental management system and OHSAS18001 occupational health and safety management system certification, and the first group to obtain the national import and export rights. Zhongke trademark is a famous trademark of Jiangsu Province. In 2010, China Science and technology group was selected as the enterprise joint pavilion of Shanghai World Expo. Zhongke group has the first-class high-standard laboratory and testing room in China, and its subordinate Nanjing Zhongke Pharmaceutical Co., Ltd. has the advanced health product production plant in China at present. The asepsis of the production workshop has reached the 10000 level standard, the main operation platform has been purified by multi-layer air, which can reach the 100 level standard, all kinds of hardware equipment have reached the advanced pharmaceutical enterprise standard, and the production area is totally closed and reaches the 100000 level standard. Zhongke focuses on the production and R & D of traditional Chinese medicine health products and strives to become a leading enterprise in the industry.

本文链接: https://brand.waitui.com/8f6a46ea2.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

苹果据悉今年9月只上iPhone18 Pro系列和首款阔折叠Fold

市场消息称,苹果iPhone 18预计明年Q1推出,9月只上iPhone18 Pro系列和首款阔折叠iPhone Fold,基本都是万元机档位。苹果今年秋季发布的所有新款iPhone都配备12GB内存,涵盖iPhone 18 Pro、iPhone 18 Pro Max以及iPhone Fold(折叠屏 iPhone),与 iPhone 17 Pro系列所采用的12GB内存保持一致。(财联社)

2小时前

美股大型科技股盘前多数上涨,英特尔涨超5%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,英特尔涨超5%,英伟达涨超2%,谷歌涨0.44%,亚马逊涨0.22%,微软涨0.31%,特斯拉涨0.19%,Meta跌0.28%,苹果跌0.19%。

2小时前

热门中概股美股盘前普涨,哔哩哔哩涨超4%

36氪获悉,热门中概股美股盘前普涨,截至发稿,哔哩哔哩涨超4%,蔚来、理想汽车涨超3%,阿里巴巴、网易、小鹏汽车涨超2%,百度涨超1%,拼多多涨0.61%,京东涨0.54%。

2小时前

星巴克:第一季度美国同店销售额增长4% 高于市场预期

星巴克第一季度美国同店销售额增长4%,预估为增长1.88%。星巴克预计全年同店销售至少增长3%,市场预估增长2.83%;预计全年调整后每股收益2.15美元至2.40美元。(财联社)

2小时前

*ST铖昌:预计2025年净利润9500万元-1.24亿元,公司股票存在可能被终止上市的风险

36氪获悉,*ST铖昌公告,*ST铖昌预计2025年归属于上市公司股东的净利润为9500万元–12400万元,上年同期为亏损3111.79万元,同比扭亏为盈。公司股票因2024年度经审计净利润为负值且扣除后营业收入低于3亿元,自2025年4月24日起被实施退市风险警示。若公司2025年度出现《深圳证券交易所股票上市规则》第9.3.12条规定的相关情形,公司股票将面临被终止上市的风险。公司已披露股票可能被终止上市的风险提示公告,并计划更换会计师事务所以推进2025年度审计工作。

2小时前

本页详细列出关于中科ZK的品牌信息,含品牌所属公司介绍,中科ZK所处行业的品牌地位及优势。
咨询